Stock Research for PSTI


Featured Broker: Ally Invest

Get the due diligence for another stock.


PSTI Stock Chart & Research Data

The PSTI chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the PSTI chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


PSTI Due diligence Resources & Stock Charts

The PSTI stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View PSTI Detailed Price Forecast - CNN Money CNN View PSTI Detailed Summary - Google Finance
Yahoo View PSTI Detailed Summary - Yahoo! Finance Zacks View PSTI Stock Research & Analysis -

Stock Analysis

TradeIdeas View PSTI Trends & Analysis - Trade-Ideas Barrons View PSTI Major Holders - Barrons
NASDAQ View PSTI Call Transcripts - NASDAQ Seeking View PSTI Breaking News & Analysis - Seeking Alpha
Spotlight View PSTI Annual Report - OTC Report View PSTI OTC Short Report -
TradeKing View PSTI Fundamentals - TradeKing Charts View PSTI SEC Filings - Bar Chart
WSJ View Historical Prices for PSTI - The WSJ Morningstar View Performance/Total Return for PSTI - Morningstar
MarketWatch View the Analyst Estimates for PSTI - MarketWatch CNBC View the Earnings History for PSTI - CNBC
StockMarketWatch View the PSTI Earnings - StockMarketWatch MacroAxis View PSTI Buy or Sell Recommendations - MacroAxis
Bullish View the PSTI Bullish Patterns - American Bulls Short Pains View PSTI Short Pain Metrics -

Social Media Mentions

StockTwits View PSTI Stock Mentions - StockTwits PennyStocks View PSTI Stock Mentions - PennyStockTweets
Twitter View PSTI Stock Mentions - Twitter Invest Hub View PSTI Investment Forum News - Investor Hub
Yahoo View PSTI Stock Mentions - Yahoo! Message Board Seeking Alpha View PSTI Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for PSTI - Insider Cow View Insider Transactions for PSTI - Insider Cow
CNBC View PSTI Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for PSTI - OTC Markets
Yahoo View Insider Transactions for PSTI - Yahoo! Finance NASDAQ View Institutional Holdings for PSTI - NASDAQ

Stock Charts

FinViz View PSTI Stock Insight & Charts - StockCharts View PSTI Investment Charts -
BarChart View PSTI Stock Overview & Charts - BarChart Trading View View PSTI User Generated Charts - Trading View

Latest Financial News for PSTI

What does Pluristem Therapeutics Inc’s (NASDAQ:PSTI) Balance Sheet Tell Us About Its Future?
Posted on Thursday September 20, 2018

Pluristem Therapeutics Inc (NASDAQ:PSTI), which has zero-debt on its balance sheet, can maximize capital returns by increasing debt due to its lower cost of capital. However, the trade-off is PSTIRead More...

Pluristem Initiates Two Pivotal Phase III Studies in Israel
Posted on Wednesday August 08, 2018

HAIFA, Israel, Aug. 08, 2018 (GLOBE NEWSWIRE) --  Pluristem Therapeutics Inc. (PSTI) (PSTI.TA), a leading developer of placenta-based cell therapy products, announced today that Israel’s Ministry of Health has cleared the Company to commence patient recruitment in Israel for two ongoing pivotal Phase III trials of PLX-PAD cell therapy, one for the treatment of Critical Limb Ischemia (CLI) and another for the treatment of muscle injury following hip fracture surgery. Both trials have been accepted to accelerated approval pathways and have received a total of $16.7 million in grants from the European Union’s Horizon 2020 Program. “We are pleased to open clinical sites in Israel for both of our ongoing pivotal Phase III studies.

Pluristem Therapeutics, Rexahn Pharma Are Biotech Winners, B Riley FBR Says In Bullish Initiation
Posted on Tuesday July 31, 2018

With hundreds of biotech stocks all assuring big prospects, building a portfolio of truly transformative medicine makers is a feat. B. Riley FBR said it's found two winners.  The Analyst Analyst  George ...

Pluristem Granted Key Patent in Japan for Treatment of GI Following Acute Radiation Exposure
Posted on Thursday July 26, 2018

Pluristem Therapeutics Inc. (PSTI) (PSTI.TA), a leading developer of placenta-based cell therapy products, announced today that the Japan Patent Office has granted Pluristem a patent for the treatment of Acute Radiation Syndrome (ARS) and its impact on the gastrointestinal tract. The patent titled “Methods for Treating Radiation or Chemical Injury” relates to intramuscular (IM) administration of adherent stromal cells, cultured under three-dimensional culturing conditions, for mitigating intestinal damage in patients that have been exposed to radiation or chemotherapy.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.